by healthadvances Posted on November 15, 2022 Let’s Talk About Vaginismus and Digital Health Read More
by healthadvances Posted on October 31, 2022November 1, 2022 Relyvrio Approval: Lessons Learned Read More
by healthadvances Posted on September 21, 2022September 22, 2022 Digitalization in Pain Management: A Painless Effort? Read More
by healthadvances Posted on July 27, 2022July 27, 2022 What Do the Next 10 Years Hold for CRISPR? Read More
by healthadvances Posted on July 6, 2022July 21, 2022 Xenotransplantation: Market Disrupter or Expander? Read More
by healthadvances Posted on June 24, 2022June 24, 2022 From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology Read More
by healthadvances Posted on June 16, 2022June 16, 2022 ASCO 2022: Striving to Ensure No Patient is Left Behind Read More
by healthadvances Posted on May 2, 2022 Opportunities and Challenges for Drug Makers in MDD Read More
by healthadvances Posted on February 25, 2022 Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases Read More
by healthadvances Posted on October 8, 2021 Building and Defending Markets; Reflections on Attending DTx and NASS Conferences Read More
by healthadvances Posted on October 1, 2021October 1, 2021 Resurgence in Drug Development for Renal Diseases Read More
by healthadvances Posted on September 29, 2021October 1, 2021 AI in Healthcare: Insights from Two Decades of FDA Approvals Read More
by healthadvances Posted on August 6, 2021August 9, 2021 Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better? Read More
by healthadvances Posted on July 21, 2021 India, the Generic Manufacturing Powerhouse, Biosimilar Next? Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on September 24, 2020October 22, 2020 When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
by healthadvances Posted on August 26, 2020August 26, 2020 eBook: Biopharma in the COVID-19 World Read More
by healthadvances Posted on August 17, 2020 Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation? Read More